DECAAF II

Efficacy of DE-MRI-Guided Fibrosis Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation (DECAAF II)

Objective

To examine the efficacy of targeting atrial fibrosis tissue during an ablation procedure in treating persistent AF.

Eligibility

  • Patients with persistent AF undergoing first AF ablation as per recent HRS consensus document. Persistent AF is defined by 7 days or more in AF as evidenced by either 1) rhythm strip or 2) written documentation.
  • Must have some proportion of atrial fibrosis (not limited to advanced stage fibrosis).

NCT ID

NCT02529319